Cargando…
Potential therapeutic effect of epigenetic therapy on treatment-induced neuroendocrine prostate cancer
Although adenocarcinomas of the prostate are relatively indolent, some patients with advanced adenocarcinomas show recurrence of treatment-induced neuroendocrine prostate cancer, which is highly aggressive and lethal. Detailed biological features of treatment-induced neuroendocrine prostate cancer h...
Autores principales: | Xu, Xiang, Huang, Yu-Hua, Li, Yan-Jing, Cohen, Alexa, Li, Zhen, Squires, Jill, Zhang, Wei, Chen, Xu-Feng, Zhang, Min, Huang, Jiao-Ti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5676429/ https://www.ncbi.nlm.nih.gov/pubmed/27905327 http://dx.doi.org/10.4103/1008-682X.191518 |
Ejemplares similares
-
Androgen-deprivation therapy-induced aggressive prostate cancer with neuroendocrine differentiation
por: Lipianskaya, Julia, et al.
Publicado: (2014) -
Neuroendocrine cells of prostate cancer: biologic functions and molecular mechanisms
por: Huang, Yu-Hua, et al.
Publicado: (2019) -
Histone demethylase PHF8 drives neuroendocrine prostate cancer progression by epigenetically upregulating FOXA2
por: Liu, Qiuli, et al.
Publicado: (2020) -
Subtype heterogeneity and epigenetic convergence in neuroendocrine prostate cancer
por: Cejas, Paloma, et al.
Publicado: (2021) -
Clinicopathological and immunological profiles of prostate adenocarcinoma and neuroendocrine prostate cancer
por: Huang, Gang, et al.
Publicado: (2022)